Overall, these studies did not show a correlative trend in regard to the hormone receptor status and the expression of gp130 cytokines, but these studies do suggest that ER may negatively regulate both LIFR and OSMR in breast cancer cells. The gene discussed is NR4A1; the disease is breast cancer.